Maryland has become the first state in the U.S. to ban stores from engaging in dynamic pricing, a controversial practice gaining traction at retailers nationwide. Gov. Wes Moore first introduced the ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

Qatar’s state oil giant QatarEnergy said on Wednesday (March 18, 2026) that “extensive damage” has been caused ‌after the Ras Laffan Industrial City was subjected to missile attacks, shortly ⁠after ...

It's draft month, and there's one Clemson Tiger who could be rising up every team's draft board until everybody's name is called. Now, that agenda might be changing. In a metric titled “relative ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

Revolution Medicines said its pancreatic cancer drug daraxonrasib succeeded in a Phase 3 trial. RevMed said its drug almost doubled the typical length of survival and slashed the risk of death by 60% ...